China's First Innovative Drug Approved NDA in the U.S.
This is the first truly innovative drug manufactured in China that passes the audits of FDA and it is about to enter the NDA progress.
Caixin Media
12.09.13
Traditional Chinese Medicine Struggling to Find Cure for Regulatory Woes in the U.S.
In November, the traditional Chinese medicine (TCM) Fuzheng Huayu Tablets passed the second phase of the U.S. Food and Drug Administration’s (FDA) clinical testing.
Before this, only one TCM drug had cleared the second of the three phases...